S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda

Moderna (MRNA) SEC Filings & 10K Form

$101.41
-0.59 (-0.58%)
(As of 04/19/2024 ET)

Recent Moderna SEC Filings

DateFilerForm TypeView
04/19/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
3:17 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2024
3:23 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
9:58 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/12/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:22 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
1:03 PM
Moderna (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
04/09/2024
3:09 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2024
2:32 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/05/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
3:20 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/29/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
3:22 PM
AFEYAN NOUBAR (Reporting)
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/22/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
7:46 AM
Moderna (Filer)
Form DEF 14A
03/21/2024
7:47 AM
Moderna (Filer)
Form DEFA14A
03/19/2024
3:39 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
11:12 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/15/2024
8:30 AM
Moderna (Filer)
Form ARS
03/13/2024
3:24 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
8:05 AM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
2:22 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
2:13 PM
Garay Arpa (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
4:52 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
2:32 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
2:25 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
4:25 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:29 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
4:33 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:28 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
3:49 PM
Garay Arpa (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
3:32 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:37 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:39 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:24 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/23/2024
3:21 PM
Moderna (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/22/2024
2:39 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/22/2024
5:32 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2024
3:20 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
2:16 PM
Bancel Stephane (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Double your money before lunch? (Ad)

Unlike bacterial infections, viral infections can be difficult to treat with medicine. Usually, if you've got a virus, your doctor's best advice is to simply rest and allow your immune system to fight back. Antiviral medications prevent viruses from reproducing, but they can't actually stop the virus. However, scientists may have just found a new way to fight back.

This unique "Cut & Paste" technique has allowed researchers to reprogram viruses to wipe each other
02/12/2024
2:39 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2024
7:42 AM
Bancel Stephane (Filed by)
Moderna (Subject)
Form SC 13G/A
01/29/2024
2:26 PM
BlackRock Inc. (Filed by)
Moderna (Subject)
Form SC 13G/A
01/29/2024
9:49 AM
BAILLIE GIFFORD & CO (Filed by)
Moderna (Subject)
Form SC 13G/A
01/08/2024
2:21 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
6:03 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
7:00 AM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
10:37 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
7:04 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
2:24 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/07/2023
3:21 PM
Garay Arpa (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
2:13 PM
Garay Arpa (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
2:43 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2023
2:30 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/29/2023
2:35 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2023
7:54 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2023
7:02 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
5:33 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/27/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
7:59 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023
3:07 PM
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2023
3:07 PM
AFEYAN NOUBAR (Reporting)
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2023
3:51 PM
Mock James M (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
6:02 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
2:17 PM
Mock James M (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/29/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
3:38 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2023
3:06 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
6:28 PM
Bancel Stephane (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
1:16 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
3:14 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2023
7:08 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2023
6:01 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2023
2:38 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
3:46 PM
Garay Arpa (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
3:17 PM
Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
2:22 PM
Garay Arpa (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2023
2:45 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2023
2:31 PM
Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2023
3:22 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/29/2023
2:36 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/25/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2023
3:14 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2023
6:01 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2023
4:16 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
“More countries ditch the US dollar” (Ad)

Since March 2018, China started purchasing oil in gold-backed yuan. By December 2022, Foreign Minister Wang Yi stated that Chinese-Arab relations experienced a "historic improvement." after arab nations ditched the dollar to trade with China. On June 6, 2023 China told its banks to slash interest rates on US dollars.

Get all the details here.
08/17/2023
11:32 AM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2023
3:11 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/04/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
5:33 AM
Moderna (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2023
6:05 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
6:00 PM
AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2023
3:12 PM
AFEYAN NOUBAR (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/18/2023
3:35 PM
Hoge Stephen (Reporting)
Moderna (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2023
12:25 PM
Hoge Stephen (Reporting)
Moderna (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MRNA) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners